122 related articles for article (PubMed ID: 36937462)
1. Determining the level of stromal and epithelial cells activity in normal and hyperplastic endometrium of late reproductive and perimenopausal women.
Chumak ZV; Artyomenko VV; Shapoval MV; Mnih LV; Kozhukhar GV; Derishov SV
J Med Life; 2023 Feb; 16(2):210-214. PubMed ID: 36937462
[TBL] [Abstract][Full Text] [Related]
2. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
5. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium.
Elhafey AS; Papadimitriou JC; El-Hakim MS; El-Said AI; Ghannam BB; Silverberg SG
Arch Pathol Lab Med; 2001 Jul; 125(7):872-9. PubMed ID: 11419970
[TBL] [Abstract][Full Text] [Related]
6. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
Ozkara SK; Corakci A
Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
[TBL] [Abstract][Full Text] [Related]
7. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
Ioffe OB; Papadimitriou JC; Drachenberg CB
Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium.
Al-Kaabi M; Noel K; Al-Rubai AJ
J Med Life; 2022 Jan; 15(1):117-123. PubMed ID: 35186145
[TBL] [Abstract][Full Text] [Related]
10. Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications.
Risberg B; Karlsson K; Abeler V; Lagrelius A; Davidson B; Karlsson MG
Int J Gynecol Pathol; 2002 Apr; 21(2):155-60. PubMed ID: 11917225
[TBL] [Abstract][Full Text] [Related]
11. Proliferative and apoptotic changes in the healthy canine endometrium and in cystic endometrial hyperplasia.
Reusche N; Beineke A; Urhausen C; Beyerbach M; Schmicke M; Kramer S; Günzel-Apel AR
Theriogenology; 2018 Jul; 114():14-24. PubMed ID: 29574305
[TBL] [Abstract][Full Text] [Related]
12. MORPHOLOGICAL CHANGES OF THE ENDOMETRIUM IN HYPERPLASTIC PROCESS IN WOMEN OF REPRODUCTIVE AGE.
Vereshchahina TV; Boychuk AV; Yakymchuk YB; Nikitina IM; Datsko TV
Wiad Lek; 2021; 74(3 cz 1):388-394. PubMed ID: 33813438
[TBL] [Abstract][Full Text] [Related]
13. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study.
Mirakhor Samani S; Ezazi Bojnordi T; Zarghampour M; Merat S; Fouladi DF
J Obstet Gynaecol; 2018 Oct; 38(7):999-1004. PubMed ID: 29560769
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.
Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M
Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186
[TBL] [Abstract][Full Text] [Related]
16. Changes in expression of some apoptotic markers in different types of human endometrium.
Driák D; Dvorská M; Svandová I; Sehnal B; Benková K; Spůrková Z; Halaška M
Folia Biol (Praha); 2011; 57(3):104-11. PubMed ID: 21888833
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium.
Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
Hum Reprod; 2001 Oct; 16(10):2211-8. PubMed ID: 11574518
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium.
Cinel L; Polat A; Aydin O; Düşmez D; Eğilmez R
Pathol Int; 2002; 52(5-6):384-9. PubMed ID: 12100521
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
20. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
Sivridis E; Giatromanolaki A; Koukourakis MI; Georgiou L; Anastasiadis P
Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]